Reactive oxygen species (ROS) are constantly generated during aerobic metabolism, as well as in response to oxidative stimuli. Although ROS are indispensable for some normal biological processes, including cell proliferation and differentiation, excess ROS or cumulative oxidative stresses result in several disease pathologies. 1) ROS may be key molecules in neuropathologic conditions, such as ischemia/reperfusion injury 2) and neurodegeneration, 3) including Parkinson's disease (PD) and Alzheimer's disease (AD). 4,5) Recently, the differential expression patterns of antioxidant enzymes that eliminate ROS, such as superoxide dismutases (SODs), catalase, glutathione peroxidases (GPXs), and peroxiredoxins (Prxs), have been detected in the brains of patients with diseases in which ROS and antioxidants appear to be associated with neurodegeneration. [6][7][8] The Prx family of antioxidant proteins, which has recently been characterized, is induced by several oxidative stress conditions and associated primarily with the removal of H 2 O 2 for the protection of cells from oxidative damages.9) In our previous study, the mapping of the distributions of all six Prx subtypes in the mouse brain by immunohistochemistry indicated specific roles for these proteins in preferential neural cell types.10) In particular, Prx I distribution was not consistent in studies from human and murine species. In human brain, Prx I was dominantly expressed in astrocytes, 11) but oligodendrocytes and schwann cells were main reservoir for Prx I in rat central and pheripheral nervous systems, respectively. 10,12) The differential results between both species indicate that the cells expressing Prx I in the brain was not determined clearly yet or controversial. Recent reports in the human pathogenic brains showed that altered expression patterns of Prxs frequently found in the brains of patients suffering from degenerative diseases, such as sporadic Creutzfeldt Jacob disease, Alzheimer's disease, Down's syndrome, and Pick's disease. 7,8) These findings suggest the involvement of Prxs in maintaining the physiological integrity of the brain against oxidative damages. Therefore, it is important to determine the intercellular distribution and roles of Prx I for the instructive clues in oxidative stress-related brain pathogenesis.Bacterial lipopolysaccharide (LPS) is present on the outer membranes of all Gram-negative bacteria. LPS activates macrophages and microglia, leading to the generation of inflammatory mediators, and it causes cell damage and death. LPS is cytotoxic for a variety of cell types via the induction of apoptosis, 13,14) which is closely related to increased levels of ROS.15,16) Although microglial death is thought to be an important parameter in neuroinflammatory processes, the effects of LPS on ROS-mediated microglial death and related signaling pathways or mechanisms are largely unknown. It has been shown that microglial death pathways are regulated by the representative ROS-dependent mitogen-activated protein kinases (MAPKs), p38 ...